Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
8.49
+0.14 (1.68%)
Nov 22, 2024, 4:00 PM EST - Market closed
Monte Rosa Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$14.67
Upside
+72.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +29.56% | Sep 12, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +100.24% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $16 | Buy | Reiterates | $16 | +88.46% | Jun 28, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +29.56% | May 22, 2024 |
| Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | +29.56% | Feb 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $11 | Buy | Maintains | $31 → $11 | +29.56% | Oct 19, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +29.56% | Aug 11, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +29.56% | May 12, 2023 |
| Credit Suisse | Credit Suisse | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +29.56% | Mar 17, 2023 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $19 | Hold → Buy | Upgrades | $19 | +123.79% | Jan 3, 2023 |
| UBS | UBS | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +159.13% | Oct 13, 2022 |
| Jefferies | Jefferies | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +135.57% | Aug 15, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $21 | Buy | Maintains | $40 → $21 | +147.35% | May 12, 2022 |
| Credit Suisse | Credit Suisse | Hold Initiates $19 | Hold | Initiates | $19 | +123.79% | Apr 28, 2022 |
| Wells Fargo | Wells Fargo | Hold Initiates $19 | Hold | Initiates | $19 | +123.79% | Feb 10, 2022 |
| SVB Leerink | SVB Leerink | Hold Initiates $20 | Hold | Initiates | $20 | +135.57% | Oct 14, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.